Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Amgen
Ownership Structure: publicly traded (ticker symbol AMGN)
Headquartered in: California
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
| State/Local | $66,314,313 | 55 |
| Federal (grants and allocated tax credits) | $0 | 0 |
| TOTAL | $66,314,313 | 55 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards: Earliest year of data: 2004. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2013.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
| Washington | $19,696,967 | 8 |
| Ohio | $15,000,000 | 1 |
| Rhode Island | $13,020,098 | 5 |
| North Carolina | $11,733,067 | 12 |
| Pennsylvania | $2,701,908 | 9 |
| All other | $4,162,273 | 20 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
| Company | Location  . | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
| IMMUNEX CORPORATION | Washington | state | 2011 | $3,568,422 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2004 | $581,065 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2005 | $581,065 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2006 | $485,991 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2007 | $3,626,627 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2008 | $3,658,748 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2009 | $3,626,627 | | tax credit/rebate |
| IMMUNEX CORPORATION | Washington | state | 2010 | $3,568,422 | | tax credit/rebate |
| Immunex Rhode Island Corp. | Rhode Island | state | 2013 | $258,315 | | tax credit/rebate |
| Immunex Rhode Island Corp. | Rhode Island | state | 2015 | $56,783 | | tax credit/rebate |
| Immunex RI Corporation | Rhode Island | state | 2018 | $6,000,000 | | tax credit/rebate |
| Immunex RI Corporation | Rhode Island | state | 2018 | $3,450,000 | | tax credit/rebate |
| Immunex RI Corporation | Rhode Island | state | 2018 | $3,255,000 | | tax credit/rebate |
| Amgen Inc. | Pennsylvania | state | 2008 | $619,437 | | tax credit/rebate |
| Amgen, Inc. | Pennsylvania | state | 2009 | $336,279 | | tax credit/rebate |
| Immunex Corporation | Pennsylvania | state | 2011 | $437,312 | | tax credit/rebate |
| Amgen USA, Inc. | Pennsylvania | state | 2011 | $5,401 | | tax credit/rebate |
| Immunex Corporation | Pennsylvania | state | 2012 | $297,513 | | tax credit/rebate |
| Immunex Corporation | Pennsylvania | state | 2013 | $319,819 | | tax credit/rebate |
| Amgen, Inc. | Pennsylvania | state | 2014 | $608,537 | | tax credit/rebate |
| Immunex Corporation | Pennsylvania | state | 2014 | $74,054 | | tax credit/rebate |
| Amgen USA, Inc. | Pennsylvania | state | 2014 | $3,556 | | tax credit/rebate |
| Amgen Inc. | Ohio | state | 2021 | $15,000,000 | | tax credit/rebate |
| Amgen USA, Inc. | North Carolina | state | 2011 | $2,572 | | tax credit/rebate |
| Amgen, Inc. | North Carolina | state | 2011 | $20,940 | | tax credit/rebate |
| Amgen USA, Inc. | North Carolina | state | 2012 | $3,274 | | tax credit/rebate |
| Amgen, Inc. | North Carolina | state | 2012 | $20,827 | | tax credit/rebate |
| Amgen, Inc. | North Carolina | state | 2013 | $7,359 | | tax credit/rebate |
| Amgen USA, Inc. | North Carolina | state | 2013 | $2,120 | | tax credit/rebate |
| Amgen USA, Inc. | North Carolina | state | 2014 | $1,644 | | tax credit/rebate |
| Amgen USA, Inc. | North Carolina | state | 2015 | $1,362 | | tax credit/rebate |
| Amgen, Inc. | North Carolina | state | 2016 | $15,489 | | tax credit/rebate |
| Amgen, Inc. | North Carolina | state | 2015 | $19,368 | | tax credit/rebate |
| Amgen, Inc. | North Carolina | state | 2010 | $25,862 | | tax credit/rebate |
| Amgen Inc. | North Carolina | state | 2021 | $11,612,250 | | grant |
| Amgen Inc. | Massachusetts | state | 2016 | $780,000 | | tax credit/rebate |
| Amgen Inc. | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2010 | $36,741 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2011 | $36,726 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2008 | $126,743 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2007 | $111,395 | | tax credit/rebate |
| Amgen Inc. | Maryland | state | 2004 | $88,478 | | tax credit/rebate |
| Amgen Inc. | Maryland | state | 2005 | $61,793 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2012 | $50,617 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2009 | $38,772 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2014 | $50,617 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2015 | $211,236 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2016 | $143,500 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2017 | $126,234 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2018 | $34,340 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2019 | $26,263 | | tax credit/rebate |
| Amgen, Inc. | Maryland | state | 2020 | $20,303 | | tax credit/rebate |
| Amgen Inc. | Maryland | state | 2021 | $22,214 | | tax credit/rebate |
| AMGEN INC | California | state | 2015 | $198,301 | | training reimbursement |
| AMGEN INC | California | state | 2018 | $198,000 | | training reimbursement |
